USRE29835E
(en)
|
1971-06-01 |
1978-11-14 |
Icn Pharmaceuticals |
1,2,4-Triazole nucleosides
|
US3798209A
(en)
|
1971-06-01 |
1974-03-19 |
Icn Pharmaceuticals |
1,2,4-triazole nucleosides
|
US3852267A
(en)
|
1972-08-04 |
1974-12-03 |
Icn Pharmaceuticals |
Phosphoramidates of 3{40 ,5{40 -cyclic purine nucleotides
|
US4526988A
(en)
|
1983-03-10 |
1985-07-02 |
Eli Lilly And Company |
Difluoro antivirals and intermediate therefor
|
NL8403224A
(nl)
|
1984-10-24 |
1986-05-16 |
Oce Andeno Bv |
Dioxafosforinanen, de bereiding ervan en de toepassing voor het splitsen van optisch actieve verbindingen.
|
US5223263A
(en)
|
1988-07-07 |
1993-06-29 |
Vical, Inc. |
Liponucleotide-containing liposomes
|
GB8719367D0
(en)
|
1987-08-15 |
1987-09-23 |
Wellcome Found |
Therapeutic compounds
|
WO1989002733A1
(en)
|
1987-09-22 |
1989-04-06 |
The Regents Of The University Of California |
Liposomal nucleoside analogues for treating aids
|
IL91664A
(en)
|
1988-09-28 |
1993-05-13 |
Yissum Res Dev Co |
Ammonium transmembrane gradient system for efficient loading of liposomes with amphipathic drugs and their controlled release
|
US6132763A
(en)
|
1988-10-20 |
2000-10-17 |
Polymasc Pharmaceuticals Plc |
Liposomes
|
US5705363A
(en)
|
1989-03-02 |
1998-01-06 |
The Women's Research Institute |
Recombinant production of human interferon τ polypeptides and nucleic acids
|
US5194654A
(en)
|
1989-11-22 |
1993-03-16 |
Vical, Inc. |
Lipid derivatives of phosphonoacids for liposomal incorporation and method of use
|
US5411947A
(en)
|
1989-06-28 |
1995-05-02 |
Vestar, Inc. |
Method of converting a drug to an orally available form by covalently bonding a lipid to the drug
|
US5463092A
(en)
|
1989-11-22 |
1995-10-31 |
Vestar, Inc. |
Lipid derivatives of phosphonacids for liposomal incorporation and method of use
|
US5026687A
(en)
|
1990-01-03 |
1991-06-25 |
The United States Of America As Represented By The Department Of Health And Human Services |
Treatment of human retroviral infections with 2',3'-dideoxyinosine alone and in combination with other antiviral compounds
|
ES2152922T3
(es)
|
1990-04-06 |
2001-02-16 |
Genelabs Tech Inc |
Epitopos del virus de la hepatitis c.
|
WO1991016920A1
(en)
|
1990-05-07 |
1991-11-14 |
Vical, Inc. |
Lipid prodrugs of salicylate and nonsteroidal anti-inflammatory drugs
|
WO1991018914A1
(en)
|
1990-05-29 |
1991-12-12 |
Vical, Inc. |
Synthesis of glycerol di- and triphosphate derivatives
|
ES2083580T3
(es)
|
1990-06-13 |
1996-04-16 |
Arnold Glazier |
Profarmacos de fosforo.
|
US6060080A
(en)
|
1990-07-16 |
2000-05-09 |
Daiichi Pharmaceutical Co., Ltd. |
Liposomal products
|
JP2599492B2
(ja)
|
1990-08-21 |
1997-04-09 |
第一製薬株式会社 |
リポソーム製剤の製造法
|
US5372808A
(en)
|
1990-10-17 |
1994-12-13 |
Amgen Inc. |
Methods and compositions for the treatment of diseases with consensus interferon while reducing side effect
|
US5543389A
(en)
|
1990-11-01 |
1996-08-06 |
State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University, A Non Profit Organization |
Covalent polar lipid-peptide conjugates for use in salves
|
US5256641A
(en)
|
1990-11-01 |
1993-10-26 |
State Of Oregon |
Covalent polar lipid-peptide conjugates for immunological targeting
|
US5543390A
(en)
|
1990-11-01 |
1996-08-06 |
State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University |
Covalent microparticle-drug conjugates for biological targeting
|
US5149794A
(en)
|
1990-11-01 |
1992-09-22 |
State Of Oregon |
Covalent lipid-drug conjugates for drug targeting
|
US5595732A
(en)
|
1991-03-25 |
1997-01-21 |
Hoffmann-La Roche Inc. |
Polyethylene-protein conjugates
|
US5157027A
(en)
|
1991-05-13 |
1992-10-20 |
E. R. Squibb & Sons, Inc. |
Bisphosphonate squalene synthetase inhibitors and method
|
EP0594677A4
(en)
|
1991-07-12 |
1997-09-17 |
Vical Inc |
Antiviral liponucleosides: treatment of hepatitis b
|
US5554728A
(en)
|
1991-07-23 |
1996-09-10 |
Nexstar Pharmaceuticals, Inc. |
Lipid conjugates of therapeutic peptides and protease inhibitors
|
TW224053B
(zh)
|
1991-09-13 |
1994-05-21 |
Paul B Chretien |
|
US5676942A
(en)
|
1992-02-10 |
1997-10-14 |
Interferon Sciences, Inc. |
Composition containing human alpha interferon species proteins and method for use thereof
|
US5405598A
(en)
|
1992-02-24 |
1995-04-11 |
Schinazi; Raymond F. |
Sensitizing agents for use in boron neutron capture therapy
|
JP3102945B2
(ja)
|
1992-02-27 |
2000-10-23 |
財団法人野田産業科学研究所 |
肝炎治療剤
|
US5610054A
(en)
|
1992-05-14 |
1997-03-11 |
Ribozyme Pharmaceuticals, Inc. |
Enzymatic RNA molecule targeted against Hepatitis C virus
|
US5426183A
(en)
|
1992-06-22 |
1995-06-20 |
Eli Lilly And Company |
Catalytic stereoselective glycosylation process for preparing 2'-deoxy-2',2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides
|
IL106075A
(en)
|
1992-06-22 |
2000-12-06 |
Lilly Co Eli |
Process for preparing alpha-anomer enriched 1-halo-2-deoxy-2,2-difluoro-alpha-D-erythropentofuranose derivatives
|
US5256798A
(en)
|
1992-06-22 |
1993-10-26 |
Eli Lilly And Company |
Process for preparing alpha-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl sulfonates
|
IL106840A
(en)
|
1992-09-01 |
1998-09-24 |
Lilly Co Eli |
Process for basic anatomization of pentopornosyl nucleosides
|
GB9226729D0
(en)
|
1992-12-22 |
1993-02-17 |
Wellcome Found |
Therapeutic combination
|
WO1994019012A2
(en)
|
1993-02-24 |
1994-09-01 |
Wang Jui H |
Compositions and methods of application of reactive antiviral polymers
|
US6180134B1
(en)
|
1993-03-23 |
2001-01-30 |
Sequus Pharmaceuticals, Inc. |
Enhanced ciruclation effector composition and method
|
EP0746319A4
(en)
|
1993-05-12 |
1997-11-05 |
Karl Y Hostetler |
ACYCLOVIR DERIVATIVES FOR TOPICAL USE
|
CA2167537A1
(en)
|
1993-07-19 |
1995-02-02 |
Tsuneo Ozeki |
Hepatitis c virus proliferation inhibitor
|
US6156501A
(en)
|
1993-10-26 |
2000-12-05 |
Affymetrix, Inc. |
Arrays of modified nucleic acid probes and methods of use
|
US7375198B2
(en)
|
1993-10-26 |
2008-05-20 |
Affymetrix, Inc. |
Modified nucleic acid probes
|
US5951974A
(en)
|
1993-11-10 |
1999-09-14 |
Enzon, Inc. |
Interferon polymer conjugates
|
EP0730470B1
(en)
|
1993-11-10 |
2002-03-27 |
Enzon, Inc. |
Improved interferon polymer conjugates
|
AU6550394A
(en)
|
1994-03-11 |
1995-09-25 |
Isis Pharmaceuticals, Inc. |
Novel pyrimidine nucleosides
|
DE4447588C2
(de)
|
1994-05-03 |
1997-11-20 |
Omer Osama Dr Dr Med |
Pflanzliches Arzneimittel zur Behandlung von chronischen und allergischen Rhino-Sino-Bronchitiden
|
WO1995035102A1
(en)
|
1994-06-22 |
1995-12-28 |
Nexstar Pharmaceuticals, Inc. |
Novel method of preparation of known and novel 2'-modified nucleosides by intramolecular nucleophilic displacement
|
DE4432623A1
(de)
|
1994-09-14 |
1996-03-21 |
Huels Chemische Werke Ag |
Verfahren zur Bleichung von wäßrigen Tensidlösungen
|
US5738846A
(en)
|
1994-11-10 |
1998-04-14 |
Enzon, Inc. |
Interferon polymer conjugates and process for preparing the same
|
US5696277A
(en)
|
1994-11-15 |
1997-12-09 |
Karl Y. Hostetler |
Antiviral prodrugs
|
US5703058A
(en)
|
1995-01-27 |
1997-12-30 |
Emory University |
Compositions containing 5-fluoro-2',3'-didehydro-2',3'-dideoxycytidine or a mono-, di-, or triphosphate thereof and a second antiviral agent
|
US6391859B1
(en)
|
1995-01-27 |
2002-05-21 |
Emory University |
[5-Carboxamido or 5-fluoro]-[2′,3′-unsaturated or 3′-modified]-pyrimidine nucleosides
|
JPH11502515A
(ja)
|
1995-02-01 |
1999-03-02 |
フラウンホファー−ゲゼルシャフト・ツァ・フェルダリュング・デア・アンゲバンテン・フォルシュング・エー・ファウ |
細胞増殖抑制剤処理における耐性形成に対する5’置換ヌクレオシドの利用と、このヌクレオシドを含む医薬品
|
GB9505025D0
(en)
|
1995-03-13 |
1995-05-03 |
Medical Res Council |
Chemical compounds
|
DE19514523A1
(de)
|
1995-04-12 |
1996-10-17 |
Schering Ag |
Neue Cytosin- und Cytidinderivate
|
DE69635864T2
(de)
|
1995-09-27 |
2006-10-26 |
Emory University |
Rekombinante rna-replikase von hepatitis-c-virus
|
US5908621A
(en)
|
1995-11-02 |
1999-06-01 |
Schering Corporation |
Polyethylene glycol modified interferon therapy
|
US5767097A
(en)
|
1996-01-23 |
1998-06-16 |
Icn Pharmaceuticals, Inc. |
Specific modulation of Th1/Th2 cytokine expression by ribavirin in activated T-lymphocytes
|
GB9602028D0
(en)
|
1996-02-01 |
1996-04-03 |
Amersham Int Plc |
Nucleoside analogues
|
US5980884A
(en)
|
1996-02-05 |
1999-11-09 |
Amgen, Inc. |
Methods for retreatment of patients afflicted with Hepatitis C using consensus interferon
|
EP0914421A2
(en)
|
1996-02-29 |
1999-05-12 |
Immusol, Inc. |
Hepatitis c virus ribozymes
|
US5830905A
(en)
|
1996-03-29 |
1998-11-03 |
Viropharma Incorporated |
Compounds, compositions and methods for treatment of hepatitis C
|
US5633388A
(en)
|
1996-03-29 |
1997-05-27 |
Viropharma Incorporated |
Compounds, compositions and methods for treatment of hepatitis C
|
US5990276A
(en)
|
1996-05-10 |
1999-11-23 |
Schering Corporation |
Synthetic inhibitors of hepatitis C virus NS3 protease
|
GB9609932D0
(en)
|
1996-05-13 |
1996-07-17 |
Hoffmann La Roche |
Use of IL-12 and IFN alpha for the treatment of infectious diseases
|
US5891874A
(en)
|
1996-06-05 |
1999-04-06 |
Eli Lilly And Company |
Anti-viral compound
|
US5837257A
(en)
|
1996-07-09 |
1998-11-17 |
Sage R&D |
Use of plant extracts for treatment of HIV, HCV and HBV infections
|
US5858389A
(en)
*
|
1996-08-28 |
1999-01-12 |
Shaker H. Elsherbini |
Squalene is an antiviral compound for treating hepatitis C virus carriers
|
US5922757A
(en)
|
1996-09-30 |
1999-07-13 |
The Regents Of The University Of California |
Treatment and prevention of hepatic disorders
|
US6509320B1
(en)
|
1996-10-16 |
2003-01-21 |
Icn Pharmaceuticals, Inc. |
Purine L-nucleosides, analogs and uses thereof
|
CZ120699A3
(cs)
|
1996-10-16 |
1999-09-15 |
Icn Pharmaceuticals, Inc. |
Monocyklická L-nukleosidová analoga a jejich využití
|
JP2001524936A
(ja)
|
1996-10-16 |
2001-12-04 |
アイ・シー・エヌ・フアーマシユーテイカルズ・インコーポレイテツド |
プリンl―ヌクレオシド類およびその用途
|
US6455690B1
(en)
|
1996-10-16 |
2002-09-24 |
Robert Tam |
L-8-oxo-7-propyl-7,8-dihydro-(9H)-guanosine
|
CA2268391A1
(en)
|
1996-10-18 |
1998-04-30 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease
|
GB9623908D0
(en)
|
1996-11-18 |
1997-01-08 |
Hoffmann La Roche |
Amino acid derivatives
|
IL119833A
(en)
|
1996-12-15 |
2001-01-11 |
Lavie David |
Hypericum perforatum extracts for the preparation of pharmaceutical compositions for the treatment of hepatitis
|
US6004933A
(en)
|
1997-04-25 |
1999-12-21 |
Cortech Inc. |
Cysteine protease inhibitors
|
EA002254B1
(ru)
|
1997-06-30 |
2002-02-28 |
Мерц + Ко. Гмбх Унд Ко. |
1-аминоалкилциклогексановые антагонисты рецепторов nmda
|
ES2234144T3
(es)
|
1997-08-11 |
2005-06-16 |
Boehringer Ingelheim (Canada) Ltd. |
Analogos de peptidos inhibidores de la hepatitis c.
|
ES2287971T3
(es)
|
1997-08-11 |
2007-12-16 |
Pfizer Products Inc. |
Dispersiones farmaceuticas solidas con biodisponibilidad incrementada.
|
PT903148E
(pt)
|
1997-09-21 |
2002-02-28 |
Schering Corp |
Terapia de combinacao para a erradicacao de rna de hcv detectavel em doentes tendo infeccao cronica pelo virus da hepatite c
|
US6703374B1
(en)
|
1997-10-30 |
2004-03-09 |
The United States Of America As Represented By The Department Of Health And Human Services |
Nucleosides for imaging and treatment applications
|
US5981709A
(en)
|
1997-12-19 |
1999-11-09 |
Enzon, Inc. |
α-interferon-polymer-conjugates having enhanced biological activity and methods of preparing the same
|
CA2317505C
(en)
|
1998-01-23 |
2011-01-04 |
Newbiotics, Inc. |
Enzyme catalyzed therapeutic agents
|
US7462605B2
(en)
|
1998-01-23 |
2008-12-09 |
Celmed Oncology (Usa), Inc. |
Phosphoramidate compounds and methods of use
|
KR100954390B1
(ko)
|
1998-02-25 |
2010-04-26 |
에모리 유니버시티 |
2'-플루오로뉴클레오사이드
|
US6787305B1
(en)
|
1998-03-13 |
2004-09-07 |
Invitrogen Corporation |
Compositions and methods for enhanced synthesis of nucleic acid molecules
|
WO1999049873A1
(en)
|
1998-03-27 |
1999-10-07 |
Regents Of The University Of Minnesota |
Nucleosides with antiviral and anticancer activity
|
GB9806815D0
(en)
|
1998-03-30 |
1998-05-27 |
Hoffmann La Roche |
Amino acid derivatives
|
SK288038B6
(en)
|
1998-05-15 |
2013-01-02 |
Merck Sharp & Dohme |
Use of ribavirin and interferon alpha for manufacture pharmaceutical compositions for treating chronic hepatitis C infection
|
ES2251196T3
(es)
|
1998-06-08 |
2006-04-16 |
F. Hoffmann-La Roche Ag |
Uso de peg-ifn-alfa y ribavirina para el tratamiento de hepatitis c cronica.
|
ES2244204T3
(es)
|
1998-07-27 |
2005-12-01 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. |
Derivados de dicetoacidos como inhibidores de polimerasas.
|
CA2340156C
(en)
|
1998-08-10 |
2007-10-23 |
Novirio Pharmaceuticals Limited |
.beta.-l-2'-deoxy-nucleosides for the treatment of hepatitis b
|
US6323180B1
(en)
|
1998-08-10 |
2001-11-27 |
Boehringer Ingelheim (Canada) Ltd |
Hepatitis C inhibitor tri-peptides
|
AU2157000A
(en)
|
1998-12-18 |
2000-07-12 |
Schering Corporation |
Ribavirin-pegylated interferon alfa induction hcv combination therapy
|
EP1027886B1
(en)
|
1999-02-10 |
2008-07-09 |
Pfizer Products Inc. |
Pharmaceutical solid dispersions
|
DE60042073D1
(de)
|
1999-07-22 |
2009-06-04 |
Celmed Oncology Usa Inc |
Enzym katalisierte therapeutische aktivierung
|
US6566365B1
(en)
|
1999-11-04 |
2003-05-20 |
Biochem Pharma Inc. |
Method for the treatment of Flaviviridea viral infection using nucleoside analogues
|
EP1232166A2
(en)
|
1999-11-12 |
2002-08-21 |
Pharmasset Limited |
Synthesis of 2'-deoxy-l-nucleosides
|
US6495677B1
(en)
|
2000-02-15 |
2002-12-17 |
Kanda S. Ramasamy |
Nucleoside compounds
|
WO2001060315A2
(en)
|
2000-02-18 |
2001-08-23 |
Shire Biochem Inc. |
Method for the treatment or prevention of flavivirus infections using nucleoside analogues
|
CN100457118C
(zh)
|
2000-04-13 |
2009-02-04 |
法玛塞特有限公司 |
用于治疗肝炎病毒感染的3′-或2′-羟甲基取代的核苷衍生物
|
EP1282632A1
(en)
|
2000-04-20 |
2003-02-12 |
Schering Corporation |
Ribavirin-interferon alfa combination therapy for eradicating detectable hcv-rna in patients having chronic hepatitis c infection
|
MY164523A
(en)
|
2000-05-23 |
2017-12-29 |
Univ Degli Studi Cagliari |
Methods and compositions for treating hepatitis c virus
|
NZ547204A
(en)
|
2000-05-26 |
2008-01-31 |
Idenix Cayman Ltd |
Methods and compositions for treating flaviviruses and pestiviruses
|
CN100490818C
(zh)
|
2000-05-26 |
2009-05-27 |
诺瓦蒂斯有限公司 |
β-L-2′-脱氧核苷在制备用于治疗丁型肝炎病毒感染的药物中的用途
|
US6787526B1
(en)
|
2000-05-26 |
2004-09-07 |
Idenix Pharmaceuticals, Inc. |
Methods of treating hepatitis delta virus infection with β-L-2′-deoxy-nucleosides
|
FR2810322B1
(fr)
|
2000-06-14 |
2006-11-10 |
Pasteur Institut |
PRODUCTION COMBINATOIRE D'ANALOGUES DE NUCLEOTIDES ET NUCLEOTIDES (XiTP)
|
MY141594A
(en)
|
2000-06-15 |
2010-05-14 |
Novirio Pharmaceuticals Ltd |
3'-PRODRUGS OF 2'-DEOXY-ß-L-NUCLEOSIDES
|
US6815542B2
(en)
|
2000-06-16 |
2004-11-09 |
Ribapharm, Inc. |
Nucleoside compounds and uses thereof
|
UA72612C2
(en)
|
2000-07-06 |
2005-03-15 |
|
Pyrido[2.3-d]pyrimidine and pyrimido[4.5-d]pyrimidine nucleoside analogues, prodrugs and method for inhibiting growth of neoplastic cells
|
AR029851A1
(es)
|
2000-07-21 |
2003-07-16 |
Dendreon Corp |
Nuevos peptidos como inhibidores de ns3-serina proteasa del virus de hepatitis c
|
AR034127A1
(es)
|
2000-07-21 |
2004-02-04 |
Schering Corp |
Imidazolidinonas como inhibidores de ns3-serina proteasa del virus de hepatitis c, composicion farmaceutica, un metodo para su preparacion, y el uso de las mismas para la manufactura de un medicamento
|
CN1446201A
(zh)
|
2000-07-21 |
2003-10-01 |
先灵公司 |
用作丙型肝炎病毒ns3-丝氨酸蛋白酶抑制剂的新型肽
|
JP2004504407A
(ja)
|
2000-07-21 |
2004-02-12 |
コルバス・インターナショナル・インコーポレイテッド |
C型肝炎ウイルスのns3−セリンプロテアーゼ阻害剤としての新規ペプチド
|
KR100749160B1
(ko)
|
2000-07-21 |
2007-08-14 |
길리애드 사이언시즈, 인코포레이티드 |
포스포네이트 뉴클레오티드 유사체의 전구 약물의 제조방법
|
US6897201B2
(en)
|
2000-08-21 |
2005-05-24 |
Inspire Pharmaceuticals, Inc. |
Compositions and methods for the treatment of glaucoma or ocular hypertension
|
US7018985B1
(en)
|
2000-08-21 |
2006-03-28 |
Inspire Pharmaceuticals, Inc. |
Composition and method for inhibiting platelet aggregation
|
AR039558A1
(es)
|
2000-08-21 |
2005-02-23 |
Inspire Pharmaceuticals Inc |
Composiciones y metodo para el tratamiento de glaucoma o hipertension ocular
|
US20030008841A1
(en)
|
2000-08-30 |
2003-01-09 |
Rene Devos |
Anti-HCV nucleoside derivatives
|
DE10046541A1
(de)
|
2000-09-19 |
2002-03-28 |
Knoll Ag |
Mechanisch stabile darreichungsformen, enthaltend Ubichinone
|
CN1646141B
(zh)
|
2000-10-18 |
2014-06-25 |
吉利德制药有限责任公司 |
用于治疗病毒感染和异常细胞增殖的修饰核苷类化合物
|
WO2002032414A2
(en)
|
2000-10-18 |
2002-04-25 |
Schering Corporation |
Ribavirin-pegylated interferon alfa hcv combination therapy
|
US6555677B2
(en)
|
2000-10-31 |
2003-04-29 |
Merck & Co., Inc. |
Phase transfer catalyzed glycosidation of an indolocarbazole
|
AU2002248147B2
(en)
|
2000-11-20 |
2006-04-06 |
Bristol-Myers Squibb Company |
Hepatitis C tripeptide inhibitors
|
KR20030091946A
(ko)
|
2000-12-12 |
2003-12-03 |
쉐링 코포레이션 |
C형 간염 바이러스의 ns3-세린 프로테아제억제제로서의 디아릴 펩티드
|
US6727366B2
(en)
|
2000-12-13 |
2004-04-27 |
Bristol-Myers Squibb Pharma Company |
Imidazolidinones and their related derivatives as hepatitis C virus NS3 protease inhibitors
|
AU2002230763A1
(en)
|
2000-12-13 |
2008-01-03 |
Bristol-Myers Squibb Pharma Company |
Inhibitors of hepatitis c virus ns3 protease
|
KR20030081343A
(ko)
|
2000-12-15 |
2003-10-17 |
파마셋, 리미티드 |
플라비비리다에 감염 치료용 항바이러스제
|
US7105499B2
(en)
|
2001-01-22 |
2006-09-12 |
Merck & Co., Inc. |
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
|
EP1355916B1
(en)
|
2001-01-22 |
2007-01-10 |
Merck & Co., Inc. |
Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
|
GB0112617D0
(en)
|
2001-05-23 |
2001-07-18 |
Hoffmann La Roche |
Antiviral nucleoside derivatives
|
GB0114286D0
(en)
|
2001-06-12 |
2001-08-01 |
Hoffmann La Roche |
Nucleoside Derivatives
|
US20050009775A1
(en)
|
2001-06-21 |
2005-01-13 |
Howes Peter David |
Nucleoside compounds in hcv
|
NZ530000A
(en)
|
2001-07-11 |
2007-03-30 |
Vertex Pharma |
Peptidomimetic bridged bicyclic serine protease inhibitors
|
JP4558314B2
(ja)
|
2001-07-20 |
2010-10-06 |
ベーリンガー インゲルハイム (カナダ) リミテッド |
ウイルスポリメラーゼインヒビター
|
EP2335700A1
(en)
|
2001-07-25 |
2011-06-22 |
Boehringer Ingelheim (Canada) Ltd. |
Hepatitis C virus polymerase inhibitors with a heterobicylic structure
|
US6962991B2
(en)
|
2001-09-12 |
2005-11-08 |
Epoch Biosciences, Inc. |
Process for the synthesis of pyrazolopyrimidines
|
EP1432721A4
(en)
|
2001-09-13 |
2008-02-20 |
Bristol Myers Squibb Co |
PROCESS FOR THE PREPARATION OF REBECCAMYCIN AND ANALOGUE THEREOF
|
WO2003024461A1
(en)
|
2001-09-20 |
2003-03-27 |
Schering Corporation |
Hcv combination therapy
|
EP1435974A4
(en)
|
2001-09-28 |
2006-09-06 |
Idenix Cayman Ltd |
METHOD AND COMPOSITIONS FOR TREATING HEPATITIS C VIRUS WITH 4'-MODIFIED NUCLEOSIDES
|
DE60221875T2
(de)
|
2001-11-02 |
2007-12-20 |
Glaxo Group Ltd., Greenford |
4-(6-gliedrige)-heteroaryl-acyl-pyrrolidinderivate als hcv-inhibitoren
|
GB0129945D0
(en)
|
2001-12-13 |
2002-02-06 |
Mrc Technology Ltd |
Chemical compounds
|
KR100978904B1
(ko)
|
2001-12-14 |
2010-08-31 |
파마셋 인코포레이티드 |
바이러스 감염 치료용 n4-아실사이토신 뉴클레오사이드
|
AU2002353165A1
(en)
|
2001-12-17 |
2003-06-30 |
Ribapharm Inc. |
Deazapurine nucleoside libraries and compounds
|
CA2470521A1
(en)
|
2001-12-21 |
2003-07-10 |
Micrologix Biotech Inc. |
Anti-viral 7-deaza l-nucleosides
|
WO2003062256A1
(en)
|
2002-01-17 |
2003-07-31 |
Ribapharm Inc. |
2'-beta-modified-6-substituted adenosine analogs and their use as antiviral agents
|
KR100758045B1
(ko)
|
2002-02-01 |
2007-09-11 |
화이자 프로덕츠 인크. |
압력 노즐을 이용하여 균질한 분무 건조된 비결정질 고체약물 분산제를 제조하는 방법
|
PT1469833T
(pt)
|
2002-02-01 |
2021-07-13 |
Bend Res Inc |
Método para produzir dispersões de fármaco amorfo sólido seco por pulverização homogéneas utilizando aparelho de secagem por pulverização modificado
|
CA2370396A1
(en)
|
2002-02-01 |
2003-08-01 |
Boehringer Ingelheim (Canada) Ltd. |
Hepatitis c inhibitor tri-peptides
|
US6642204B2
(en)
|
2002-02-01 |
2003-11-04 |
Boehringer Ingelheim International Gmbh |
Hepatitis C inhibitor tri-peptides
|
WO2003068244A1
(en)
|
2002-02-13 |
2003-08-21 |
Merck & Co., Inc. |
Methods of inhibiting orthopoxvirus replication with nucleoside compounds
|
EP1485395A4
(en)
|
2002-02-28 |
2011-04-13 |
Biota Scient Management |
NUCLEOTIDE MIMETICS AND PRODRUGS THEREOF
|
US20040023901A1
(en)
|
2002-02-28 |
2004-02-05 |
Cook Phillip D. |
Nucleoside 5'-monophosphate mimics and their prodrugs
|
US20040014108A1
(en)
|
2002-05-24 |
2004-01-22 |
Eldrup Anne B. |
Oligonucleotides having modified nucleoside units
|
WO2003106477A1
(en)
|
2002-06-01 |
2003-12-24 |
Isis Pharmaceuticals, Inc. |
Oligomeric compounds that include carbocyclic nucleosides and their use in gene modulation
|
MXPA04012245A
(es)
|
2002-06-04 |
2005-09-30 |
Neogenesis Pharmaceuticals Inc |
Compuestos de pirazolo[1,5a]pirimidina como agentes antivirales.
|
WO2003104250A1
(en)
|
2002-06-07 |
2003-12-18 |
Kylix, B. V. |
New compounds for modulating the activity of exchange proteins directly activated by camp (epacs)
|
AU2003251524A1
(en)
|
2002-06-17 |
2003-12-31 |
Isis Pharmaceuticals, Inc. |
Carbocyclic nucleoside analogs as RNA-antivirals
|
WO2004000858A2
(en)
|
2002-06-21 |
2003-12-31 |
Merck & Co., Inc. |
Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
|
US20060234962A1
(en)
|
2002-06-27 |
2006-10-19 |
Olsen David B |
Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
|
JP2005533824A
(ja)
|
2002-06-28 |
2005-11-10 |
イデニクス(ケイマン)リミテツド |
フラビウイルス科感染の治療のための2’−c−メチル−3’−o−l−バリンエステルリボフラノシルシチジン
|
MXPA04012709A
(es)
|
2002-06-28 |
2005-09-30 |
Idenix Cayman Ltd |
Profarmacos modificados de 2'- y 3'-nucleosido para tratar infecciones por flaviviridae.
|
KR20050055630A
(ko)
|
2002-06-28 |
2005-06-13 |
이데닉스 (케이만) 리미티드 |
플라비비리다에 감염 치료를 위한 1'-, 2'- 및 3'-변형된뉴클레오시드 유도체
|
US7608600B2
(en)
|
2002-06-28 |
2009-10-27 |
Idenix Pharmaceuticals, Inc. |
Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
|
CN1761677A
(zh)
|
2002-06-28 |
2006-04-19 |
埃迪尼克斯(开曼)有限公司 |
用于治疗黄病毒感染的修饰的2'和3'-核苷前药
|
BR0305426A
(pt)
|
2002-07-01 |
2004-08-24 |
Upjohn Co |
Compostos inibidores de ns5b polimerase de hcv, bem como composição farmacêutica compreendendo os mesmos
|
MXPA05000256A
(es)
|
2002-07-01 |
2005-07-15 |
Upjohn Co |
Inhibidores de polimerasa ns5b del vhc.
|
EP1556399A4
(en)
|
2002-07-16 |
2007-09-26 |
Merck & Co Inc |
NUCLEOSIDE DERIVATIVES AS RNA-DEPENDENT VIRAL RNA POLYMERASE INHIBITORS
|
EP1572709A3
(en)
|
2002-07-24 |
2005-11-23 |
PTC Therapeutics, Inc. |
Use of nucleoside compounds for nonsense suppression and the treatment of genetic diseases
|
AU2003256619A1
(en)
|
2002-07-24 |
2004-02-09 |
Isis Pharmaceuticals, Inc. |
Pyrrolopyrimidine thionucleoside analogs as antivirals
|
US20050026853A1
(en)
|
2002-07-25 |
2005-02-03 |
Micrologix Biotech Inc. |
Anti-viral 7-deaza D-nucleosides and uses thereof
|
US20050069522A1
(en)
|
2002-08-12 |
2005-03-31 |
Richard Colonno |
Combination pharmaceutical agents as inhibitors of HCV replication
|
SI1572095T1
(sl)
|
2002-09-13 |
2015-12-31 |
Novartis Ag |
Beta-l-2'-deoksinukleozidi za uporabo pri zdravljenju odpornih sevov hbv
|
JP2006505571A
(ja)
|
2002-10-15 |
2006-02-16 |
リゲル ファーマシューテイカルズ、インコーポレイテッド |
置換されたインドール及びhcv阻害剤としてのその使用
|
US20040229840A1
(en)
|
2002-10-29 |
2004-11-18 |
Balkrishen Bhat |
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
|
HN2003000348A
(es)
|
2002-11-01 |
2008-10-14 |
Viropharma Inc |
Compuestos de benzofurano, composiciones y metodos para tratamiento y profilaxis de infeccion virales de hepatitis c y enfermedades asociadas.
|
WO2004046331A2
(en)
|
2002-11-15 |
2004-06-03 |
Idenix (Cayman) Limited |
2’-branched nucleosides and flaviviridae mutation
|
TWI332507B
(en)
|
2002-11-19 |
2010-11-01 |
Hoffmann La Roche |
Antiviral nucleoside derivatives
|
WO2004052899A2
(en)
|
2002-12-12 |
2004-06-24 |
Idenix (Cayman) Limited |
Process for the production of 2'-branched nucleosides
|
US7259186B2
(en)
|
2002-12-17 |
2007-08-21 |
Abbott Laboratories |
Salts of fenofibric acid and pharmaceutical formulations thereof
|
US7223785B2
(en)
|
2003-01-22 |
2007-05-29 |
Boehringer Ingelheim International Gmbh |
Viral polymerase inhibitors
|
AU2003225705A1
(en)
|
2003-03-07 |
2004-09-30 |
Ribapharm Inc. |
Cytidine analogs and methods of use
|
WO2004084453A2
(en)
|
2003-03-20 |
2004-09-30 |
Microbiologica Quimica E Farmaceutica Ltd. |
METHODS OF MANUFACTURE OF 2'-DEOXY-β-L-NUCLEOSIDES
|
ATE422895T1
(de)
|
2003-04-16 |
2009-03-15 |
Bristol Myers Squibb Co |
Makrocyclische isochinolinpeptidinhibitoren des hepatitis-c-virus
|
US20050261237A1
(en)
|
2003-04-25 |
2005-11-24 |
Boojamra Constantine G |
Nucleoside phosphonate analogs
|
EA014685B1
(ru)
|
2003-04-25 |
2010-12-30 |
Джилид Сайэнс, Инк. |
Фосфонатсодержащие антивирусные соединения (варианты) и фармацевтическая композиция на их основе
|
US7452901B2
(en)
|
2003-04-25 |
2008-11-18 |
Gilead Sciences, Inc. |
Anti-cancer phosphonate analogs
|
KR20060061930A
(ko)
|
2003-04-25 |
2006-06-08 |
길리애드 사이언시즈, 인코포레이티드 |
항암성 포스포네이트 유사체
|
US7470724B2
(en)
|
2003-04-25 |
2008-12-30 |
Gilead Sciences, Inc. |
Phosphonate compounds having immuno-modulatory activity
|
US7407965B2
(en)
|
2003-04-25 |
2008-08-05 |
Gilead Sciences, Inc. |
Phosphonate analogs for treating metabolic diseases
|
AU2004233897A1
(en)
|
2003-04-25 |
2004-11-11 |
Gilead Sciences, Inc. |
Kinase inhibitor phosphonate conjugates
|
WO2005002626A2
(en)
|
2003-04-25 |
2005-01-13 |
Gilead Sciences, Inc. |
Therapeutic phosphonate compounds
|
WO2004096210A1
(en)
|
2003-05-01 |
2004-11-11 |
Glaxo Group Limited |
Acylated indoline and tetrahydroquinoline derivatives as hcv inhibitors
|
US20040259934A1
(en)
|
2003-05-01 |
2004-12-23 |
Olsen David B. |
Inhibiting Coronaviridae viral replication and treating Coronaviridae viral infection with nucleoside compounds
|
ES2456702T3
(es)
|
2003-05-09 |
2014-04-23 |
Boehringer Ingelheim International Gmbh |
Bolsillo de unión del inhibidor de la polimerasa NS5B del virus de la hepatitis C
|
US20040229839A1
(en)
|
2003-05-14 |
2004-11-18 |
Biocryst Pharmaceuticals, Inc. |
Substituted nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases
|
WO2005020884A2
(en)
|
2003-05-14 |
2005-03-10 |
Idenix (Cayman) Limited |
Nucleosides for treatment of infection by corona viruses, toga viruses and picorna viruses
|
WO2004106356A1
(en)
|
2003-05-27 |
2004-12-09 |
Syddansk Universitet |
Functionalized nucleotide derivatives
|
WO2005003147A2
(en)
|
2003-05-30 |
2005-01-13 |
Pharmasset, Inc. |
Modified fluorinated nucleoside analogues
|
EP1644479A4
(en)
|
2003-06-16 |
2008-04-23 |
Mark W Grinstaff |
MACROMOLECULES AND FUNCTIONAL SYNTHETIC MOLECULES FOR GENES ADMINISTRATION
|
RU2243972C1
(ru)
|
2003-06-26 |
2005-01-10 |
Государственный научный центр вирусологии и биотехнологии "Вектор" |
Фосфорамидаты нуклеозидных аналогов - ингибиторы репродукции вируса иммунодефицита человека
|
MXPA06000162A
(es)
|
2003-06-30 |
2006-03-21 |
Idenix Cayman Ltd |
Sintesis de ?-l-2-desoxinucleosidos.
|
GB0317009D0
(en)
|
2003-07-21 |
2003-08-27 |
Univ Cardiff |
Chemical compounds
|
ATE478886T1
(de)
|
2003-07-25 |
2010-09-15 |
Idenix Pharmaceuticals Inc |
Purin nucleoside für die behandlung von durch flavividrae verursachten krankheiten, einschliesslich hepatitis c
|
DE602004029904D1
(de)
|
2003-08-27 |
2010-12-16 |
Biota Scient Management |
Neue tricyclische nukleoside oder nukleotide als therapeutische mittel
|
US20050119189A1
(en)
|
2003-09-18 |
2005-06-02 |
Cottrell Kevin M. |
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
|
US20050148534A1
(en)
|
2003-09-22 |
2005-07-07 |
Castellino Angelo J. |
Small molecule compositions and methods for increasing drug efficiency using compositions thereof
|
US7348389B2
(en)
|
2003-09-22 |
2008-03-25 |
E. I. Du Pont De Nemours And Company |
Method for achieving recoat adhesion over a fluorinated topcoat
|
CA2540858C
(en)
|
2003-10-14 |
2009-12-08 |
Intermune, Inc. |
Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of hcv replication
|
US7491794B2
(en)
|
2003-10-14 |
2009-02-17 |
Intermune, Inc. |
Macrocyclic compounds as inhibitors of viral replication
|
US7026339B2
(en)
|
2003-11-07 |
2006-04-11 |
Fan Yang |
Inhibitors of HCV NS5B polymerase
|
TW200528459A
(en)
|
2004-01-06 |
2005-09-01 |
Achillion Pharmaceuticals Inc |
Azabenzofuran substituted thioureas; inhibitors of viral replication
|
US20070155731A1
(en)
|
2004-01-28 |
2007-07-05 |
Gabor Butora |
Aminocyclopentyl pyridopyrazinone modulators of chemokine receptor activity
|
AU2005216971A1
(en)
|
2004-02-25 |
2005-09-09 |
Government Of The United States Of America, As Represented By The Secretary Department Of Health And Human Services Office Of Technology Transfer |
Methylation inhibitor compounds
|
US7157492B2
(en)
|
2004-02-26 |
2007-01-02 |
Wyeth |
Dibenzo chromene derivatives and their use as ERβ selective ligands
|
WO2005087788A2
(en)
|
2004-03-04 |
2005-09-22 |
The Regents Of The University Of California |
Methods for preparation of nucleoside phosphonate esters
|
AU2005228894B9
(en)
|
2004-03-30 |
2011-10-13 |
Intermune, Inc. |
Macrocyclic compounds as inhibitors of viral replication
|
GB0408995D0
(en)
|
2004-04-22 |
2004-05-26 |
Glaxo Group Ltd |
Compounds
|
KR101370580B1
(ko)
|
2004-06-08 |
2014-03-06 |
버텍스 파마슈티칼스 인코포레이티드 |
약학 조성물
|
US7534767B2
(en)
|
2004-06-15 |
2009-05-19 |
Merck & Co., Inc. |
C-purine nucleoside analogs as inhibitors of RNA-dependent RNA viral polymerase
|
WO2006000922A2
(en)
|
2004-06-23 |
2006-01-05 |
Idenix (Cayman) Limited |
5-aza-7-deazapurine derivatives for treating infections with flaviviridae
|
CA2571079A1
(en)
|
2004-06-24 |
2006-02-02 |
Merck & Co., Inc. |
Nucleoside aryl phosphoramidates for the treatment of rna-dependent rna viral infection
|
US7217523B2
(en)
|
2004-07-02 |
2007-05-15 |
Regents Of The University Of Minnesota |
Nucleoside phosphoramidates and nucleoside phosphoramidases
|
CN101023094B
(zh)
|
2004-07-21 |
2011-05-18 |
法莫赛特股份有限公司 |
烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备
|
KR101235548B1
(ko)
|
2004-07-21 |
2013-02-21 |
길리어드 파마셋 엘엘씨 |
2'-데옥시-2'-플루오로-2'-C-메틸-β-D-리보퓨라노실 뉴클레오사이드의 제조 방법
|
ATE505196T1
(de)
|
2004-07-27 |
2011-04-15 |
Gilead Sciences Inc |
Nukleosid phosphonat konjugate als anti hiv mittel
|
US7348425B2
(en)
|
2004-08-09 |
2008-03-25 |
Bristol-Myers Squibb Company |
Inhibitors of HCV replication
|
US7153848B2
(en)
|
2004-08-09 |
2006-12-26 |
Bristol-Myers Squibb Company |
Inhibitors of HCV replication
|
CA2577526A1
(en)
|
2004-08-23 |
2006-03-02 |
Joseph Armstrong Martin |
Antiviral 4'-azido-nucleosides
|
ATE437875T1
(de)
|
2004-08-23 |
2009-08-15 |
Hoffmann La Roche |
Heterozyklische antivirale verbindungen
|
WO2006029081A2
(en)
|
2004-09-02 |
2006-03-16 |
Neopharm, Inc. |
Nucleoside-lipid conjugates, their method of preparation and uses thereof
|
EP1809301B1
(en)
|
2004-09-14 |
2019-11-06 |
Gilead Pharmasset LLC |
2-fluoro-2-alkyl-substituted d-ribonolactone intermediates
|
FR2875409B1
(fr)
|
2004-09-17 |
2010-05-07 |
Sanofi Aventis |
Composition pharmaceutique comprenant une dispersion solide a matrice polymere comprenant une phase continue de polydextrose et une phase continue d'un polymere autre que du polydextrose
|
JP2008514639A
(ja)
|
2004-09-24 |
2008-05-08 |
イデニクス(ケイマン)リミテツド |
フラビウイルス、ペスチウイルス及びヘパシウイルスの感染症を治療するための方法及び組成物
|
KR20070058602A
(ko)
|
2004-09-30 |
2007-06-08 |
티보텍 파마슈티칼즈 리미티드 |
Hcv 저해 바이-사이클릭 피리미딘
|
AU2005317081A1
(en)
|
2004-10-21 |
2006-06-22 |
Merck & Co., Inc. |
Fluorinated pyrrolo[2,3-d]pyrimidine nucleosides for the treatment of RNA-dependent RNA viral infection
|
NZ555441A
(en)
|
2004-10-29 |
2010-12-24 |
Biocryst Pharm Inc |
Therapeutic furopyrimidines and thienopyrimidines
|
JP2008523082A
(ja)
|
2004-12-09 |
2008-07-03 |
リージェンツ オブ ザ ユニバーシティ オブ ミネソタ |
抗菌活性および抗癌活性を有するヌクレオチド
|
EP1828217A2
(en)
|
2004-12-16 |
2007-09-05 |
Febit Biotech GmbH |
Polymerase-independent analysis of the sequence of polynucleotides
|
WO2006065590A2
(en)
|
2004-12-16 |
2006-06-22 |
Xtl Biopharmaceuticals Inc. |
Pyridine and pyrimidine antiviral compositions
|
EP1674104A1
(en)
|
2004-12-24 |
2006-06-28 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Uridine derivatives as antiviral drugs against a flaviviridae, especially HCV
|
CN100528875C
(zh)
|
2005-02-18 |
2009-08-19 |
美德(江西)生物科技有限公司 |
无结晶型态的印地普隆及其制备方法
|
WO2006093801A1
(en)
|
2005-02-25 |
2006-09-08 |
Abbott Laboratories |
Thiadiazine derivatives useful as anti-infective agents
|
US7524825B2
(en)
|
2005-02-28 |
2009-04-28 |
Smithkline Beecham Corporation |
Tricyclic-nucleoside compounds for treating viral infections
|
JP2008534479A
(ja)
|
2005-03-25 |
2008-08-28 |
テイボテク・フアーマシユーチカルズ・リミテツド |
Hcvの複素二環式阻害剤
|
AR056327A1
(es)
|
2005-04-25 |
2007-10-03 |
Genelabs Tech Inc |
Compuestos de nucleosidos para el tratamiento de infecciones virales
|
WO2006121820A1
(en)
|
2005-05-05 |
2006-11-16 |
Valeant Research & Development |
Phosphoramidate prodrugs for treatment of viral infection
|
AR054122A1
(es)
|
2005-05-12 |
2007-06-06 |
Tibotec Pharm Ltd |
Pirido[2,3-d]pirimidas utiles como inhibidores de hcv, y metodos para la preparacion de las mismas
|
AR056347A1
(es)
|
2005-05-12 |
2007-10-03 |
Tibotec Pharm Ltd |
Uso de compuestos de pteridina para fabricar medicamentos y composiciones farmaceuticas
|
WO2007027248A2
(en)
|
2005-05-16 |
2007-03-08 |
Valeant Research & Development |
3', 5' - cyclic nucleoside analogues for treatment of hcv
|
US8143288B2
(en)
|
2005-06-06 |
2012-03-27 |
Bristol-Myers Squibb Company |
Inhibitors of HCV replication
|
US20060293752A1
(en)
|
2005-06-27 |
2006-12-28 |
Missoum Moumene |
Intervertebral disc prosthesis and associated methods
|
EP2305697A3
(en)
|
2005-07-25 |
2011-07-27 |
Intermune, Inc. |
Macrocyclic inhibitors of Hepatitis C virus replication
|
BRPI0614637A2
(pt)
|
2005-07-29 |
2011-04-12 |
Tibotec Pharm Ltd |
inibidores macrocìclicos do vìrus da hepatite c
|
PL1919898T3
(pl)
|
2005-07-29 |
2011-06-30 |
Tibotec Pharm Ltd |
Makrocykliczne inhibitory wirusa zapalenia wątroby typu C
|
PE20070211A1
(es)
|
2005-07-29 |
2007-05-12 |
Medivir Ab |
Compuestos macrociclicos como inhibidores del virus de hepatitis c
|
US8012939B2
(en)
|
2005-07-29 |
2011-09-06 |
Tibotec Pharmaceuticals Ltd. Co |
Macrocyclic inhibitors of hepatitis C virus
|
RU2441870C2
(ru)
|
2005-07-29 |
2012-02-10 |
Тиботек Фармасьютикалз Лтд. |
Макроциклические ингибиторы вируса гепатита с
|
EP1928475B1
(en)
|
2005-08-15 |
2018-05-23 |
Riboscience LLC |
Antiviral phosphoramidates of 4'-c-azido-substituted pronucleotides
|
GB0519478D0
(en)
|
2005-09-23 |
2005-11-02 |
Glaxo Group Ltd |
Compounds
|
GB0519488D0
(en)
|
2005-09-23 |
2005-11-02 |
Glaxo Group Ltd |
Compounds
|
CA2632626C
(en)
|
2005-12-09 |
2011-10-11 |
F. Hoffmann-La Roche Ag |
Ester prodrugs of 2'-fluoro-2'-alkyl-2'-deoxycytidines and their use in the treatment of hcv infection
|
RU2008128452A
(ru)
|
2005-12-12 |
2010-01-20 |
Дженелабс Текнолоджис, Инк. (Us) |
Соединения n-(6-членных арил)-амидов, фармацевтическая композиция с противовирусной активностью на их основе, способ лечения или профилактики вирусной инфекции с их помощью и способ их получения
|
JP2009521479A
(ja)
|
2005-12-21 |
2009-06-04 |
アボット・ラボラトリーズ |
抗ウイルス化合物
|
GB0602046D0
(en)
|
2006-02-01 |
2006-03-15 |
Smithkline Beecham Corp |
Compounds
|
WO2007092000A1
(en)
|
2006-02-06 |
2007-08-16 |
Bristol-Myers Squibb Company |
Inhibitors of hcv replication
|
EP1832281A1
(en)
|
2006-03-10 |
2007-09-12 |
Abbott GmbH & Co. KG |
Process for producing a solid dispersion of an active ingredient
|
JP2009526850A
(ja)
|
2006-02-14 |
2009-07-23 |
メルク エンド カムパニー インコーポレーテッド |
Rna依存性rnaウイルス感染を治療するためのヌクレオシドアリールホスホルアミデート
|
WO2007093901A1
(en)
|
2006-02-17 |
2007-08-23 |
Pfizer Limited |
3 -deazapurine derivatives as tlr7 modulators
|
US20070218138A1
(en)
|
2006-03-20 |
2007-09-20 |
Bittorf Kevin J |
Pharmaceutical Compositions
|
US8895531B2
(en)
|
2006-03-23 |
2014-11-25 |
Rfs Pharma Llc |
2′-fluoronucleoside phosphonates as antiviral agents
|
DE602007006796D1
(de)
|
2006-05-25 |
2010-07-08 |
Bristol Myers Squibb Co |
Cyclopropyl-fusionierte indolbenzazepin-hcv-ns5b-hemmer
|
US8891379B2
(en)
|
2006-06-02 |
2014-11-18 |
Riverbed Technology, Inc. |
Traffic flow inference based on link loads and gravity measures
|
KR20140004808A
(ko)
|
2006-07-07 |
2014-01-13 |
길리애드 사이언시즈, 인코포레이티드 |
치료제의 약동학 특성의 모듈레이터
|
EP1881001A1
(en)
|
2006-07-20 |
2008-01-23 |
Tibotec Pharmaceuticals Ltd. |
HCV NS-3 serine protease inhibitors
|
US7659270B2
(en)
|
2006-08-11 |
2010-02-09 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US8329159B2
(en)
|
2006-08-11 |
2012-12-11 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US7759495B2
(en)
|
2006-08-11 |
2010-07-20 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US8303944B2
(en)
|
2006-08-11 |
2012-11-06 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
RU2421461C2
(ru)
|
2006-10-10 |
2011-06-20 |
Фармассет, Инк. |
Способ получения рибофуранозил-пиримидиновых нуклеозидов
|
PL216525B1
(pl)
|
2006-10-17 |
2014-04-30 |
Ct Badań Molekularnych I Makromolekularnych Polskiej Akademii Nauk |
5'-O-[(N-acylo)amidoditiofosforano] nukleozydy oraz sposób wytwarzania 5'-O-[(N-acylo)amidofosforano]-,5'-O-[(N-acylo)amidotiofosforano]-, 5'-O-[(N-acylo)amidoditiofosforano]nukleozydów
|
GB0623493D0
(en)
|
2006-11-24 |
2007-01-03 |
Univ Cardiff |
Chemical compounds
|
US20090291138A1
(en)
*
|
2006-12-07 |
2009-11-26 |
Daiichi Sankyo Company, Limited |
Film-coated preparation having improved stability
|
US8148349B2
(en)
|
2006-12-20 |
2012-04-03 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. |
Nucleoside cyclic phosphoramidates for the treatment of RNA-dependent RNA viral infection
|
US20080261913A1
(en)
|
2006-12-28 |
2008-10-23 |
Idenix Pharmaceuticals, Inc. |
Compounds and pharmaceutical compositions for the treatment of liver disorders
|
JP2010515680A
(ja)
|
2007-01-05 |
2010-05-13 |
メルク・シャープ・エンド・ドーム・コーポレイション |
Rna依存性rnaウイルス感染症の治療用としてのヌクレオシドアリールホスホロアミデート
|
EP2144921A2
(en)
|
2007-02-27 |
2010-01-20 |
K.U. Leuven Research and Development |
Phosphate modified nucleosides useful as substrates for polymerases and as antiviral agents
|
US7964580B2
(en)
|
2007-03-30 |
2011-06-21 |
Pharmasset, Inc. |
Nucleoside phosphoramidate prodrugs
|
US7741347B2
(en)
|
2007-05-17 |
2010-06-22 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
GB0709791D0
(en)
|
2007-05-22 |
2007-06-27 |
Angeletti P Ist Richerche Bio |
Antiviral agents
|
US20100160335A1
(en)
|
2007-06-19 |
2010-06-24 |
Kyorin Pharmaceutical Co., Ltd. |
Pyridazinone derivative and pde inhibitor containing the same as active ingredient
|
MX2009013827A
(es)
|
2007-06-29 |
2010-03-01 |
Gilead Sciences Inc |
Compuestos antivirales.
|
CN101108870A
(zh)
|
2007-08-03 |
2008-01-23 |
冷一欣 |
核苷磷酸酯类化合物及制备方法和应用
|
US8629171B2
(en)
|
2007-08-08 |
2014-01-14 |
Bristol-Myers Squibb Company |
Crystalline form of methyl ((1S)-1-((25)-2-(5-(4'-(2-((25)-1((2S)-2-((methoxycarbonyl)amino)-3-methylbutanoyl)-2-pyrrolidinyl)-1H-imidazol-2-yl)-1-pyrrolidinyl)carbonyl)-2-methylpropyl)carbamate dihydrochloride salt
|
US7728027B2
(en)
|
2007-08-08 |
2010-06-01 |
Bristol-Myers Squibb Company |
Process for synthesizing compounds useful for treating hepatitis C
|
JO2778B1
(en)
|
2007-10-16 |
2014-03-15 |
ايساي انك |
Certain vehicles, installations and methods
|
BRPI0818339A2
(pt)
|
2007-10-19 |
2015-04-22 |
Abbott Gmbh & Co Kg |
Produto de dispersão sólida contendo composto à base de n-aril uréia
|
US20090176732A1
(en)
|
2007-12-21 |
2009-07-09 |
Alios Biopharma Inc. |
Protected nucleotide analogs
|
EP2250163B1
(en)
|
2008-02-12 |
2012-03-28 |
Bristol-Myers Squibb Company |
Hepatitis c virus inhibitors
|
BRPI0822323A2
(pt)
|
2008-02-13 |
2015-06-16 |
Bristol Myers Squibb Co |
Imidazolil bifenil imidazóis como inibidores do vírus da hepatite c
|
US7704992B2
(en)
|
2008-02-13 |
2010-04-27 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US8147818B2
(en)
|
2008-02-13 |
2012-04-03 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US8227431B2
(en)
|
2008-03-17 |
2012-07-24 |
Hetero Drugs Limited |
Nucleoside derivatives
|
WO2009120878A2
(en)
|
2008-03-26 |
2009-10-01 |
Alnylam Pharmaceuticals, Inc. |
Non-natural ribonucleotides, and methods of use thereof
|
WO2009129120A2
(en)
|
2008-04-15 |
2009-10-22 |
Rfs Pharma, Llc |
Nucleoside derivatives for treatment of caliciviridae infections, including norovirus infections
|
US8173621B2
(en)
|
2008-06-11 |
2012-05-08 |
Gilead Pharmasset Llc |
Nucleoside cyclicphosphates
|
EP2321297A1
(en)
|
2008-07-10 |
2011-05-18 |
Prosidion Limited |
Piperidinyl gpcr agonists
|
US20110111434A1
(en)
|
2008-07-15 |
2011-05-12 |
Huang Emina H |
Colon stem cells associated with colitisand colorectal cancer and methods of use
|
EP2323631A1
(en)
|
2008-08-07 |
2011-05-25 |
Schering Corporation |
Pharmaceutical formulations of an hcv protease inhibitor in a solid molecular dispersion
|
US7906655B2
(en)
|
2008-08-07 |
2011-03-15 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
CN102231990B
(zh)
*
|
2008-08-13 |
2013-09-25 |
沃泰克斯药物股份有限公司 |
N-[2,4-双(1,1-二甲基乙基)-5-羟基苯基]-1,4-二氢-4-氧代喹啉-3-甲酰胺的药物组合物和其给药
|
US20100256184A1
(en)
*
|
2008-08-13 |
2010-10-07 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical composition and administrations thereof
|
US8383094B2
(en)
|
2008-10-01 |
2013-02-26 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
WO2010042834A1
(en)
|
2008-10-09 |
2010-04-15 |
Anadys Pharmaceuticals, Inc. |
A method of inhibiting hepatitis c virus by combination of a 5,6-dihydro-1h-pyridin-2-one and one or more additional antiviral compounds
|
US8729077B2
(en)
|
2008-11-28 |
2014-05-20 |
Glaxosmithkline Llc |
Anti-viral compounds, compositions, and methods of use
|
NZ593806A
(en)
|
2008-12-03 |
2014-04-30 |
Presidio Pharmaceuticals Inc |
Inhibitors of hcv ns5a
|
CN104163816A
(zh)
|
2008-12-03 |
2014-11-26 |
普雷西迪奥制药公司 |
Hcv ns5a的抑制剂
|
US8551973B2
(en)
|
2008-12-23 |
2013-10-08 |
Gilead Pharmasset Llc |
Nucleoside analogs
|
US8716263B2
(en)
|
2008-12-23 |
2014-05-06 |
Gilead Pharmasset Llc |
Synthesis of purine nucleosides
|
EP3222628A1
(en)
|
2008-12-23 |
2017-09-27 |
Gilead Pharmasset LLC |
Nucleoside phosphoramidates
|
CA2748792A1
(en)
|
2009-01-07 |
2010-07-15 |
Samuel Earl Hopkins |
Combination of a cyclosporine derivative and nucleosides for treating hcv
|
EP2393359A4
(en)
|
2009-02-09 |
2012-10-03 |
Enanta Pharm Inc |
COMPOUND DIBENZIMIDAZOLE DERIVATIVES
|
TWI438200B
(zh)
|
2009-02-17 |
2014-05-21 |
必治妥美雅史谷比公司 |
C型肝炎病毒抑制劑
|
WO2010096462A1
(en)
|
2009-02-17 |
2010-08-26 |
Enanta Pharmaceuticals, Inc |
Linked diimidazole derivatives
|
WO2010096777A1
(en)
|
2009-02-23 |
2010-08-26 |
Presidio Pharmaceuticals, Inc. |
Inhibitors of hcv ns5a
|
UY32462A
(es)
|
2009-02-23 |
2010-09-30 |
Arrow Therapeutics Ltd |
Derivados de bifenilo novedosos para el tratamiento de infección por virus de hepatitis c 644
|
DK2401272T3
(en)
|
2009-02-27 |
2017-02-27 |
Janssen Pharmaceuticals Inc |
AMORF SALT OF A MACROCYCLIC INHIBITOR OF HCV
|
KR20130130875A
(ko)
|
2009-02-27 |
2013-12-02 |
이난타 파마슈티칼스, 인코포레이티드 |
C형 간염 바이러스 억제제
|
WO2010108140A1
(en)
|
2009-03-20 |
2010-09-23 |
Alios Biopharma, Inc. |
Substituted nucleoside and nucleotide analogs
|
WO2010111673A1
(en)
|
2009-03-27 |
2010-09-30 |
Presidio Pharmaceuticals, Inc. |
Substituted bicyclic hcv inhibitors
|
CN102427729B
(zh)
|
2009-03-27 |
2014-09-03 |
默沙东公司 |
丙型肝炎病毒复制的抑制剂
|
BRPI1012282A2
(pt)
|
2009-03-27 |
2015-09-22 |
Presidio Pharmaceuticals Inc |
inibidores de anel fundidos da hepatite c.
|
TWI476190B
(zh)
|
2009-03-30 |
2015-03-11 |
必治妥美雅史谷比公司 |
C型肝炎病毒抑制劑
|
US8796466B2
(en)
|
2009-03-30 |
2014-08-05 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
TW201038559A
(en)
|
2009-04-09 |
2010-11-01 |
Bristol Myers Squibb Co |
Hepatitis C virus inhibitors
|
US8143414B2
(en)
|
2009-04-13 |
2012-03-27 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
EP2419404B1
(en)
|
2009-04-15 |
2015-11-04 |
AbbVie Inc. |
Anti-viral compounds
|
US8436036B2
(en)
|
2009-04-24 |
2013-05-07 |
Janssen R&D Ireland |
Diaryl ethers
|
WO2010132538A1
(en)
|
2009-05-12 |
2010-11-18 |
Schering Corporation |
Fused tricyclic aryl compounds useful for the treatment of viral diseases
|
CA2761258C
(en)
|
2009-05-13 |
2015-08-04 |
Gilead Sciences, Inc. |
Antiviral compounds
|
US8618076B2
(en)
|
2009-05-20 |
2013-12-31 |
Gilead Pharmasset Llc |
Nucleoside phosphoramidates
|
TWI576352B
(zh)
|
2009-05-20 |
2017-04-01 |
基利法瑪席特有限責任公司 |
核苷磷醯胺
|
JP2012528194A
(ja)
|
2009-05-29 |
2012-11-12 |
メルク・シャープ・アンド・ドーム・コーポレーション |
C型肝炎などの疾患を処置するための3つの整列型アリール部分で構成された抗菌性化合物
|
US8211928B2
(en)
|
2009-05-29 |
2012-07-03 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
WO2010138791A1
(en)
|
2009-05-29 |
2010-12-02 |
Schering Corporation |
Antiviral compounds composed of three linked aryl moieties to treat diseases such as hepatitis c
|
US8138215B2
(en)
|
2009-05-29 |
2012-03-20 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US8937150B2
(en)
|
2009-06-11 |
2015-01-20 |
Abbvie Inc. |
Anti-viral compounds
|
CN103819459B
(zh)
|
2009-06-11 |
2017-05-17 |
艾伯维巴哈马有限公司 |
抗病毒化合物
|
US8221737B2
(en)
|
2009-06-16 |
2012-07-17 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
WO2010148006A1
(en)
|
2009-06-16 |
2010-12-23 |
Enanta Pharmaceuticals, Inc. |
Hepatitis c virus inhibitors
|
WO2011004276A1
(en)
|
2009-07-06 |
2011-01-13 |
Pfizer Limited |
Hepatitis c virus inhibitors
|
CA2767887A1
(en)
|
2009-07-16 |
2011-01-20 |
Vertex Pharmaceuticals Incorporated |
Benzimidazole analogues for the treatment or prevention of flavivirus infections
|
EP2462135A1
(en)
|
2009-08-07 |
2012-06-13 |
Janssen R&D Ireland |
Bis-benzimidazole derivatives as hepatitis c virus inhibitors
|
CN102471323A
(zh)
|
2009-08-07 |
2012-05-23 |
泰博特克药品公司 |
苯基乙炔基衍生物作为丙型肝炎病毒抑制剂
|
FR2949465B1
(fr)
|
2009-09-01 |
2011-08-12 |
Pf Medicament |
Derives chromones, leur procede de preparation et leurs applications therapeutiques
|
AU2010291215A1
(en)
|
2009-09-03 |
2012-02-23 |
Janssen Sciences Ireland Uc |
Bis-benzimidazole derivatives
|
EP2473056A4
(en)
|
2009-09-04 |
2013-02-13 |
Glaxosmithkline Llc |
CHEMICAL COMPOUNDS
|
US9156818B2
(en)
|
2009-09-11 |
2015-10-13 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
EP2475254A4
(en)
|
2009-09-11 |
2013-05-22 |
Enanta Pharm Inc |
HEPATITIS C-VIRUS HEMMER
|
US8415374B2
(en)
|
2009-10-12 |
2013-04-09 |
Bristol-Myers Squibb Company |
Combinations of hepatitis C virus inhibitors
|
WO2011050146A1
(en)
|
2009-10-23 |
2011-04-28 |
Glaxosmithkline Llc |
Chemical compounds
|
UA108211C2
(uk)
|
2009-11-04 |
2015-04-10 |
Янссен Рід Айрленд |
Бензімідазолімідазольні похідні
|
US20110274648A1
(en)
|
2009-11-11 |
2011-11-10 |
Bristol-Myers Squibb Company |
Hepatitis C Virus Inhibitors
|
US20110269956A1
(en)
|
2009-11-11 |
2011-11-03 |
Bristol-Myers Squibb Company |
Hepatitis C Virus Inhibitors
|
US20110281910A1
(en)
|
2009-11-12 |
2011-11-17 |
Bristol-Myers Squibb Company |
Hepatitis C Virus Inhibitors
|
US20120276047A1
(en)
|
2009-11-25 |
2012-11-01 |
Rosenblum Stuart B |
Fused tricyclic compounds and derivatives thereof useful for the treatment of viral diseases
|
US20110137633A1
(en)
|
2009-12-03 |
2011-06-09 |
Abbott Laboratories |
Anti-viral compounds and methods of identifying the same
|
US8476225B2
(en)
|
2009-12-04 |
2013-07-02 |
Gilead Sciences, Inc. |
Antiviral compounds
|
US8653070B2
(en)
|
2009-12-14 |
2014-02-18 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
US8377980B2
(en)
|
2009-12-16 |
2013-02-19 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
CA2784748A1
(en)
|
2009-12-18 |
2011-06-23 |
Idenix Pharmaceuticals, Inc. |
5,5-fused arylene or heteroarylene hepatitis c virus inhibitors
|
US20110152246A1
(en)
|
2009-12-18 |
2011-06-23 |
Intermune, Inc. |
Novel inhibitors of hepatitis c virus replication
|
EP2516430B1
(en)
|
2009-12-22 |
2014-11-05 |
Merck Sharp & Dohme Corp. |
Fused tricyclic compounds and methods of use thereof for the treatment of viral diseases
|
MX2012007420A
(es)
|
2009-12-24 |
2012-07-23 |
Vertex Pharma |
Analogos para el tratamiento o prevencion de infecciones de flavivirus.
|
US8362020B2
(en)
|
2009-12-30 |
2013-01-29 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
WO2011091446A1
(en)
|
2010-01-22 |
2011-07-28 |
Glaxosmithkline Llc |
Chemical compounds
|
AU2011224698A1
(en)
|
2010-03-09 |
2012-11-01 |
Merck Sharp & Dohme Corp. |
Fused Tricyclic Silyl Compounds and methods of use thereof for the treatment of viral diseases
|
PT3290428T
(pt)
*
|
2010-03-31 |
2021-12-27 |
Gilead Pharmasset Llc |
Comprimido compreendendo 2-(((s)-(((2r,3r,4r,5r)-5-(2,4-dioxo-3,4-dihidropirimidin-1-(2h)-il)¿4¿fluoro¿3¿hidroxi¿4¿metiltetrahidrofuran¿2¿il)metoxi) (fenoxi)fosforil)amino)propanoato de (s)- isopropil cristalino
|
US9125904B1
(en)
|
2010-05-11 |
2015-09-08 |
Achillion Pharmaceuticals, Inc. |
Biphenyl imidazoles and related compounds useful for treating HCV infections
|
US20110312996A1
(en)
|
2010-05-17 |
2011-12-22 |
Intermune, Inc. |
Novel inhibitors of hepatitis c virus replication
|
CA2797872A1
(en)
|
2010-05-21 |
2011-11-24 |
Gilead Sciences, Inc. |
Heterocyclic flaviviridae virus inhibitors
|
UY33445A
(es)
|
2010-06-10 |
2012-01-31 |
Gilead Sciences Inc |
Un régimen de dosificación, métodos para tratar el virus de la hepatitis c, composición farmacéutica, compuesta, compuestos anti-hcv y kit
|
NZ605440A
(en)
|
2010-06-10 |
2014-05-30 |
Abbvie Bahamas Ltd |
Solid compositions comprising an hcv inhibitor
|
EP2963034A1
(en)
|
2010-08-26 |
2016-01-06 |
RFS Pharma, LLC. |
Potent and selective inhibitors of hepatitis c virus
|
KR20140001879A
(ko)
|
2010-09-29 |
2014-01-07 |
머크 샤프 앤드 돔 코포레이션 |
C형 간염 바이러스 감염을 치료하기 위한 테트라시클릭 인돌 유도체
|
WO2012048421A1
(en)
|
2010-10-14 |
2012-04-19 |
Boehringer Ingelheim International Gmbh |
Hepatitis c inhibitor compounds
|
US20120107278A1
(en)
|
2010-10-29 |
2012-05-03 |
Pharmasset, Inc. |
Abbreviated hcv therapy for hcv infected patients with il28b c/c genotype
|
KR20200140924A
(ko)
*
|
2010-11-17 |
2020-12-16 |
길리애드 파마셋 엘엘씨 |
항바이러스 화합물
|
TW201701876A
(zh)
|
2010-12-20 |
2017-01-16 |
吉李德科學股份有限公司 |
治療c型肝炎病毒(hcv)之方法
|
WO2012087976A2
(en)
|
2010-12-21 |
2012-06-28 |
Intermune, Inc. |
Novel inhibitors of hepatitis c virus replication
|
EP2562223A1
(de)
|
2011-08-26 |
2013-02-27 |
Sika Technology AG |
Zweikomponentige Zusammensetzung auf Basis von silanfunktionellen Polymeren
|
ME03009B
(me)
|
2011-09-16 |
2018-10-20 |
Gilead Pharmasset Llc |
Metode za lecenje hcv-a
|
US8492386B2
(en)
|
2011-10-21 |
2013-07-23 |
Abbvie Inc. |
Methods for treating HCV
|
US8466159B2
(en)
|
2011-10-21 |
2013-06-18 |
Abbvie Inc. |
Methods for treating HCV
|
CN104383541A
(zh)
|
2011-10-21 |
2015-03-04 |
艾伯维公司 |
用于治疗hcv的包含至少两种直接抗病毒剂和利巴韦林但无干扰素的方法
|
SE1450131A1
(sv)
|
2011-10-21 |
2014-05-07 |
Abbvie Inc |
DAA-kombinationsbehandling (t.ex. med ABT-072 eller ABT-333)för användning vid behandling av HCV
|
US20130109647A1
(en)
*
|
2011-10-31 |
2013-05-02 |
Gilead Pharmasset Llc |
Methods and compositions for treating hepatitis c virus
|
ES2687291T3
(es)
|
2011-11-16 |
2018-10-24 |
Gilead Pharmasset Llc |
Imidazolilimidazoles condensados como compuestos antivirales
|
US8889159B2
(en)
|
2011-11-29 |
2014-11-18 |
Gilead Pharmasset Llc |
Compositions and methods for treating hepatitis C virus
|
CA2857339C
(en)
|
2011-12-29 |
2015-11-17 |
Abbvie Inc. |
Solid compositions comprising an hcv inhibitor
|
US9034832B2
(en)
|
2011-12-29 |
2015-05-19 |
Abbvie Inc. |
Solid compositions
|
US9079887B2
(en)
|
2012-05-16 |
2015-07-14 |
Gilead Sciences, Inc. |
Antiviral compounds
|
US20130309196A1
(en)
|
2012-05-16 |
2013-11-21 |
Gilead Sciences, Inc. |
Antiviral compounds
|
WO2013177188A1
(en)
|
2012-05-22 |
2013-11-28 |
Idenix Pharmaceuticals, Inc. |
3',5'-cyclic phosphoramidate prodrugs for hcv infection
|
US8969588B2
(en)
|
2012-06-05 |
2015-03-03 |
Gilead Pharmasset Llc |
Solid forms of an antiviral compound
|
US9056860B2
(en)
|
2012-06-05 |
2015-06-16 |
Gilead Pharmasset Llc |
Synthesis of antiviral compound
|
AR091279A1
(es)
|
2012-06-08 |
2015-01-21 |
Gilead Sciences Inc |
Inhibidores macrociclicos de virus flaviviridae
|
UA119315C2
(uk)
|
2012-07-03 |
2019-06-10 |
Гіліад Фармассет Елелсі |
Інгібітори вірусу гепатиту с
|
US8841340B2
(en)
|
2012-08-17 |
2014-09-23 |
Gilead Sciences, Inc. |
Solid forms of an antiviral compound
|
US9233974B2
(en)
|
2012-12-21 |
2016-01-12 |
Gilead Sciences, Inc. |
Antiviral compounds
|
JP2015508418A
(ja)
|
2013-01-31 |
2015-03-19 |
ギリアド ファーマセット エルエルシー |
2種の抗ウイルス化合物のコンビナトリアル製剤
|
KR20140098706A
(ko)
|
2013-01-31 |
2014-08-08 |
닛토덴코 가부시키가이샤 |
에폭시 조성물 및 에폭시 수지 성형품
|
WO2014185995A1
(en)
|
2013-05-16 |
2014-11-20 |
Gilead Pharmasset Llc |
Hepatitis c treatments with sofosbuvir
|
EP4005560A1
(en)
|
2013-08-27 |
2022-06-01 |
Gilead Pharmasset LLC |
Combination formulation of two antiviral compounds
|
US20150064252A1
(en)
|
2013-08-27 |
2015-03-05 |
Gilead Pharmasset Llc |
Solid dispersion formulation of an antiviral compound
|
WO2015084741A2
(en)
|
2013-12-02 |
2015-06-11 |
Gilead Pharmasset Llc |
Methods of treating hepatitis c virus infection in subjects with cirrhosis
|
TWI721947B
(zh)
|
2014-06-11 |
2021-03-21 |
美商基利法瑪席特有限責任公司 |
抗病毒化合物的固態形式
|
TWI679203B
(zh)
|
2014-06-11 |
2019-12-11 |
美商基利法瑪席特有限責任公司 |
製備抗病毒化合物之方法
|
JP2016051146A
(ja)
|
2014-09-02 |
2016-04-11 |
ウシオ電機株式会社 |
光検出装置
|